Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis stocks and ETFs experienced a significant rally, with Trulieve Cannabis Corp. surging 35% and the Roundhill Cannabis ETF (WEED) climbing 29.4%, following reports that President Trump is considering reclassifying marijuana from Schedule I to Schedule III. This potential shift would allow cannabis companies to claim standard business tax deductions, expand banking access, and facilitate medical research, thereby legitimizing the multi-billion-dollar industry and potentially paving the way for broader market expansion and investment.

Analysis

The cannabis sector experienced a significant rally driven by reports that the U.S. administration is considering reclassifying marijuana from a Schedule I to a Schedule III substance. This potential regulatory shift triggered substantial gains across the industry, with individual stocks like Trulieve Cannabis Corp. (TRUL) surging 35% and Tilray (TLRY) jumping 32%, while ETFs such as the Roundhill Cannabis ETF (WEED) climbed 29.4%. The market's strong positive reaction reflects the material benefits of such a change, which would allow cannabis companies to claim standard business tax deductions, gain improved access to banking services, and attract institutional investment. Reclassification would fundamentally alter the financial and operational landscape for U.S. operators by alleviating punitive tax burdens and institutionalizing the industry, potentially accelerating medical research and encouraging further state-level legalization. With a decision reportedly expected in the coming weeks, the sector is currently trading on a powerful, short-term catalyst, though the gains are contingent on a political decision that is not yet finalized.

Key Decisions for Investors

• Given the rally is based on a potential regulatory change, investors should closely monitor White House announcements, as the outcome represents a significant binary event for the sector with high associated volatility.
• Consider differentiating between investment vehicles based on geographic focus; ETFs like AdvisorShares Pure US Cannabis ETF (MSOS), which concentrates on U.S. multi-state operators, are positioned to benefit most directly from U.S. tax and banking reforms, unlike funds with heavier Canadian exposure like AdvisorShares Pure Cannabis ETF (YOLO).
• The sharp price increases present significant near-term risk; investors should be prepared for a potential reversal if reclassification is delayed or denied, or a possible 'sell the news' reaction if it is confirmed.